Global Seasonal Influenza Vaccines Market Research Report 2020

Publisher Name :
Date: 07-Feb-2020
No. of pages: 99
Inquire Before Buying

This report focuses on Seasonal Influenza Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Seasonal Influenza Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

- GlaxoSmithKline plc

- Sinovac Biotech Ltd

- Changsheng Bio-Technology

- Ccbio SA

- Aleph Biomedical

- Sanofi

- Jiangsu Simcere Vaxtec Bio-pharmaceutical

- Dalian Hissen Bio-pharm

- Abbott Laboratories

- Novartis International AG

Segment by Regions

- North America

- Europe

- China

- Japan

Segment by Type

- Type A (H1N1)

- Type A (H3N2)

- Type B

Segment by Application

- Pediatrics

- Adolescence

- Adults

- Elderly

Global Seasonal Influenza Vaccines Market Research Report 2020

Table of Contents
1 Seasonal Influenza Vaccines Market Overview
1.1 Product Overview and Scope of Seasonal Influenza Vaccines
1.2 Seasonal Influenza Vaccines Segment by Type
1.2.1 Global Seasonal Influenza Vaccines Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Type A (H1N1)
1.2.3 Type A (H3N2)
1.2.4 Type B
1.3 Seasonal Influenza Vaccines Segment by Application
1.3.1 Seasonal Influenza Vaccines Sales Comparison by Application: 2020 VS 2026
1.3.2 Pediatrics
1.3.3 Adolescence
1.3.4 Adults
1.3.5 Elderly
1.4 Global Seasonal Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Seasonal Influenza Vaccines Revenue 2015-2026
1.4.2 Global Seasonal Influenza Vaccines Sales 2015-2026
1.4.3 Seasonal Influenza Vaccines Market Size by Region: 2020 Versus 2026
2 Global Seasonal Influenza Vaccines Market Competition by Manufacturers
2.1 Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2015-2020)
2.3 Global Seasonal Influenza Vaccines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Seasonal Influenza Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Seasonal Influenza Vaccines Market Competitive Situation and Trends
2.5.1 Seasonal Influenza Vaccines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Seasonal Influenza Vaccines Players (Opinion Leaders)
3 Seasonal Influenza Vaccines Retrospective Market Scenario by Region
3.1 Global Seasonal Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Seasonal Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Seasonal Influenza Vaccines Market Facts & Figures by Country
3.3.1 North America Seasonal Influenza Vaccines Sales by Country
3.3.2 North America Seasonal Influenza Vaccines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Seasonal Influenza Vaccines Market Facts & Figures by Country
3.4.1 Europe Seasonal Influenza Vaccines Sales by Country
3.4.2 Europe Seasonal Influenza Vaccines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Seasonal Influenza Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Seasonal Influenza Vaccines Sales by Region
3.5.2 Asia Pacific Seasonal Influenza Vaccines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Seasonal Influenza Vaccines Market Facts & Figures by Country
3.6.1 Latin America Seasonal Influenza Vaccines Sales by Country
3.6.2 Latin America Seasonal Influenza Vaccines Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Seasonal Influenza Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Country
3.7.2 Middle East and Africa Seasonal Influenza Vaccines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Seasonal Influenza Vaccines Historic Market Analysis by Type
4.1 Global Seasonal Influenza Vaccines Sales Market Share by Type (2015-2020)
4.2 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2015-2020)
4.3 Global Seasonal Influenza Vaccines Price Market Share by Type (2015-2020)
4.4 Global Seasonal Influenza Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Seasonal Influenza Vaccines Historic Market Analysis by Application
5.1 Global Seasonal Influenza Vaccines Sales Market Share by Application (2015-2020)
5.2 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2015-2020)
5.3 Global Seasonal Influenza Vaccines Price by Application (2015-2020)
6 Company Profiles and Key Figures in Seasonal Influenza Vaccines Business
6.1 GlaxoSmithKline plc
6.1.1 Corporation Information
6.1.2 GlaxoSmithKline plc Description, Business Overview and Total Revenue
6.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GlaxoSmithKline plc Products Offered
6.1.5 GlaxoSmithKline plc Recent Development
6.2 Sinovac Biotech Ltd
6.2.1 Sinovac Biotech Ltd Seasonal Influenza Vaccines Production Sites and Area Served
6.2.2 Sinovac Biotech Ltd Description, Business Overview and Total Revenue
6.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sinovac Biotech Ltd Products Offered
6.2.5 Sinovac Biotech Ltd Recent Development
6.3 Changsheng Bio-Technology
6.3.1 Changsheng Bio-Technology Seasonal Influenza Vaccines Production Sites and Area Served
6.3.2 Changsheng Bio-Technology Description, Business Overview and Total Revenue
6.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Changsheng Bio-Technology Products Offered
6.3.5 Changsheng Bio-Technology Recent Development
6.4 Ccbio SA
6.4.1 Ccbio SA Seasonal Influenza Vaccines Production Sites and Area Served
6.4.2 Ccbio SA Description, Business Overview and Total Revenue
6.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ccbio SA Products Offered
6.4.5 Ccbio SA Recent Development
6.5 Aleph Biomedical
6.5.1 Aleph Biomedical Seasonal Influenza Vaccines Production Sites and Area Served
6.5.2 Aleph Biomedical Description, Business Overview and Total Revenue
6.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Aleph Biomedical Products Offered
6.5.5 Aleph Biomedical Recent Development
6.6 Sanofi
6.6.1 Sanofi Seasonal Influenza Vaccines Production Sites and Area Served
6.6.2 Sanofi Description, Business Overview and Total Revenue
6.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Sanofi Products Offered
6.6.5 Sanofi Recent Development
6.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
6.6.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Production Sites and Area Served
6.6.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Products Offered
6.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development
6.8 Dalian Hissen Bio-pharm
6.8.1 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Production Sites and Area Served
6.8.2 Dalian Hissen Bio-pharm Description, Business Overview and Total Revenue
6.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Dalian Hissen Bio-pharm Products Offered
6.8.5 Dalian Hissen Bio-pharm Recent Development
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Seasonal Influenza Vaccines Production Sites and Area Served
6.9.2 Abbott Laboratories Description, Business Overview and Total Revenue
6.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Abbott Laboratories Products Offered
6.9.5 Abbott Laboratories Recent Development
6.10 Novartis International AG
6.10.1 Novartis International AG Seasonal Influenza Vaccines Production Sites and Area Served
6.10.2 Novartis International AG Description, Business Overview and Total Revenue
6.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Novartis International AG Products Offered
6.10.5 Novartis International AG Recent Development
7 Seasonal Influenza Vaccines Manufacturing Cost Analysis
7.1 Seasonal Influenza Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Seasonal Influenza Vaccines
7.4 Seasonal Influenza Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Seasonal Influenza Vaccines Distributors List
8.3 Seasonal Influenza Vaccines Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Seasonal Influenza Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Seasonal Influenza Vaccines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Seasonal Influenza Vaccines by Type (2021-2026)
10.2 Seasonal Influenza Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Seasonal Influenza Vaccines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Seasonal Influenza Vaccines by Application (2021-2026)
10.3 Seasonal Influenza Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Seasonal Influenza Vaccines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Seasonal Influenza Vaccines by Region (2021-2026)
10.4 North America Seasonal Influenza Vaccines Estimates and Projections (2021-2026)
10.5 Europe Seasonal Influenza Vaccines Estimates and Projections (2021-2026)
10.6 Asia Pacific Seasonal Influenza Vaccines Estimates and Projections (2021-2026)
10.7 Latin America Seasonal Influenza Vaccines Estimates and Projections (2021-2026)
10.8 Middle East and Africa Seasonal Influenza Vaccines Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Seasonal Influenza Vaccines Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Seasonal Influenza Vaccines Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Seasonal Influenza Vaccines Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Seasonal Influenza Vaccines Manufacturers Covered in This Study
Table 5. Global Seasonal Influenza Vaccines Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Seasonal Influenza Vaccines Sales Share by Manufacturers (2015-2020)
Table 7. Global Seasonal Influenza Vaccines Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Seasonal Influenza Vaccines Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Seasonal Influenza Vaccines Sales Sites and Area Served
Table 11. Manufacturers Seasonal Influenza Vaccines Product Types
Table 12. Global Seasonal Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Seasonal Influenza Vaccines Players
Table 16. Global Seasonal Influenza Vaccines Sales (K Units) by Region (2015-2020)
Table 17. Global Seasonal Influenza Vaccines Sales Market Share by Region (2015-2020)
Table 18. Global Seasonal Influenza Vaccines Revenue (Million US$) by Region (2015-2020)
Table 19. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2015-2020)
Table 20. North America Seasonal Influenza Vaccines Sales by Country (2015-2020) (K Units)
Table 21. North America Seasonal Influenza Vaccines Sales Market Share by Country (2015-2020)
Table 22. North America Seasonal Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Seasonal Influenza Vaccines Revenue Market Share by Country (2015-2020)
Table 24. Europe Seasonal Influenza Vaccines Sales by Country (2015-2020) (K Units)
Table 25. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2015-2020)
Table 26. Europe Seasonal Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Seasonal Influenza Vaccines Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Seasonal Influenza Vaccines Revenue Market Share by Region (2015-2020)
Table 32. Latin America Seasonal Influenza Vaccines Sales by Country (2015-2020) (K Units)
Table 33. Latin America Seasonal Influenza Vaccines Sales Market Share by Country (2015-2020)
Table 34. Latin America Seasonal Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Seasonal Influenza Vaccines Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Seasonal Influenza Vaccines Revenue Market Share by Country (2015-2020)
Table 40. Global Seasonal Influenza Vaccines Sales (K Units) by Type (2015-2020)
Table 41. Global Seasonal Influenza Vaccines Sales Share by Type (2015-2020)
Table 42. Global Seasonal Influenza Vaccines Revenue (Million US$) by Type (2015-2020)
Table 43. Global Seasonal Influenza Vaccines Revenue Share by Type (2015-2020)
Table 44. Global Seasonal Influenza Vaccines Price (USD/Unit) by Type (2015-2020)
Table 45. Global Seasonal Influenza Vaccines Sales (K Units) by Application (2015-2020)
Table 46. Global Seasonal Influenza Vaccines Sales Market Share by Application (2015-2020)
Table 47. Global Seasonal Influenza Vaccines Sales Growth Rate by Application (2015-2020)
Table 48. GlaxoSmithKline plc Seasonal Influenza Vaccines Corporation Information
Table 49. GlaxoSmithKline plc Description and Business Overview
Table 50. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. GlaxoSmithKline plc Main Product
Table 52. GlaxoSmithKline plc Recent Development
Table 53. Sinovac Biotech Ltd Seasonal Influenza Vaccines Corporation Information
Table 54. Sinovac Biotech Ltd Corporation Information
Table 55. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Sinovac Biotech Ltd Main Product
Table 57. Sinovac Biotech Ltd Recent Development
Table 58. Changsheng Bio-Technology Seasonal Influenza Vaccines Corporation Information
Table 59. Changsheng Bio-Technology Corporation Information
Table 60. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Changsheng Bio-Technology Main Product
Table 62. Changsheng Bio-Technology Recent Development
Table 63. Ccbio SA Seasonal Influenza Vaccines Corporation Information
Table 64. Ccbio SA Corporation Information
Table 65. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Ccbio SA Main Product
Table 67. Ccbio SA Recent Development
Table 68. Aleph Biomedical Seasonal Influenza Vaccines Corporation Information
Table 69. Aleph Biomedical Corporation Information
Table 70. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Aleph Biomedical Main Product
Table 72. Aleph Biomedical Recent Development
Table 73. Sanofi Seasonal Influenza Vaccines Corporation Information
Table 74. Sanofi Corporation Information
Table 75. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Sanofi Main Product
Table 77. Sanofi Recent Development
Table 78. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Corporation Information
Table 79. Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
Table 80. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Jiangsu Simcere Vaxtec Bio-pharmaceutical Main Product
Table 82. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development
Table 83. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Corporation Information
Table 84. Dalian Hissen Bio-pharm Corporation Information
Table 85. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Dalian Hissen Bio-pharm Main Product
Table 87. Dalian Hissen Bio-pharm Recent Development
Table 88. Abbott Laboratories Seasonal Influenza Vaccines Corporation Information
Table 89. Abbott Laboratories Corporation Information
Table 90. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Abbott Laboratories Main Product
Table 92. Abbott Laboratories Recent Development
Table 93. Novartis International AG Seasonal Influenza Vaccines Corporation Information
Table 94. Novartis International AG Corporation Information
Table 95. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Novartis International AG Main Product
Table 97. Novartis International AG Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Seasonal Influenza Vaccines Distributors List
Table 101. Seasonal Influenza Vaccines Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Seasonal Influenza Vaccines Sales (K Units) Forecast by Type (2021-2026)
Table 106. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Seasonal Influenza Vaccines Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Seasonal Influenza Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Seasonal Influenza Vaccines Sales (K Units) Forecast by Application (2021-2026)
Table 110. Global Seasonal Influenza Vaccines Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Seasonal Influenza Vaccines Sales (K Units) Forecast by Region (2021-2026)
Table 112. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Seasonal Influenza Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Seasonal Influenza Vaccines
Figure 2. Global Seasonal Influenza Vaccines Sales Market Share by Type: 2020 VS 2026
Figure 3. Type A (H1N1) Product Picture
Figure 4. Type A (H3N2) Product Picture
Figure 5. Type B Product Picture
Figure 6. Global Seasonal Influenza Vaccines Consumption Market Share by Application: 2020 VS 2026
Figure 7. Pediatrics
Figure 8. Adolescence
Figure 9. Adults
Figure 10. Elderly
Figure 11. Global Seasonal Influenza Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Seasonal Influenza Vaccines Sales Capacity (K Units) (2015-2026)
Figure 13. Global Seasonal Influenza Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Seasonal Influenza Vaccines Sales Share by Manufacturers in 2020
Figure 15. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Seasonal Influenza Vaccines Revenue in 2019
Figure 17. Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Seasonal Influenza Vaccines Sales Market Share by Region (2015-2020)
Figure 19. Global Seasonal Influenza Vaccines Sales Market Share by Region in 2019
Figure 20. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2015-2020)
Figure 21. Global Seasonal Influenza Vaccines Revenue Market Share by Region in 2019
Figure 22. North America Seasonal Influenza Vaccines Sales Market Share by Country in 2019
Figure 23. North America Seasonal Influenza Vaccines Revenue Market Share by Country in 2019
Figure 24. U.S. Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Seasonal Influenza Vaccines Sales Market Share by Country in 2019
Figure 29. Europe Seasonal Influenza Vaccines Revenue Market Share by Country in 2019
Figure 30. Germany Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Region in 2019
Figure 41. Asia Pacific Seasonal Influenza Vaccines Revenue Market Share by Region in 2019
Figure 42. China Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Seasonal Influenza Vaccines Sales Market Share by Country in 2019
Figure 65. Latin America Seasonal Influenza Vaccines Revenue Market Share by Country in 2019
Figure 66. Mexico Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Seasonal Influenza Vaccines Revenue Market Share by Country in 2019
Figure 74. Turkey Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Seasonal Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. U.A.E Seasonal Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Seasonal Influenza Vaccines by Type (2015-2020)
Figure 81. Sales Market Share of Seasonal Influenza Vaccines by Type in 2019
Figure 82. Revenue Share of Seasonal Influenza Vaccines by Type (2015-2020)
Figure 83. Revenue Market Share of Seasonal Influenza Vaccines by Type in 2019
Figure 84. Global Seasonal Influenza Vaccines Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Seasonal Influenza Vaccines Sales Market Share by Application (2015-2020)
Figure 86. Global Seasonal Influenza Vaccines Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Seasonal Influenza Vaccines by Application (2015-2020)
Figure 88. Global Revenue Share of Seasonal Influenza Vaccines by Application in 2020
Figure 89. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sinovac Biotech Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Changsheng Bio-Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Ccbio SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Aleph Biomedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Jiangsu Simcere Vaxtec Bio-pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Dalian Hissen Bio-pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of Seasonal Influenza Vaccines
Figure 101. Manufacturing Process Analysis of Seasonal Influenza Vaccines
Figure 102. Seasonal Influenza Vaccines Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America Seasonal Influenza Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. North America Seasonal Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Seasonal Influenza Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Seasonal Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Seasonal Influenza Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Seasonal Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Seasonal Influenza Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Seasonal Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Seasonal Influenza Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Seasonal Influenza Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs